Cleveland, OH, May 1, 2008 – Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds including the North Coast Angel Fund JumpStart Inc., Everett Partners, Ltd, Ohio TechAngel Fund and Case Technology Ventures. The Company intends to use the funds to finalize the pre-clinical development and initiate pivotal clinical study of B-Lock™, an antimicrobial and heparin-free antithrombotic catheter lock solution. More…PDF(42Kb) [...]
|
|||
|
Cleveland, Ohio, (January 30, 2008) – Great Lakes Pharmaceuticals, Inc. announced today that it has entered into exclusive license agreements with The Board of Regents of The University of Texas System, acting on behalf of The University of Texas M. D. Anderson Cancer Center (“UTMDACC”), and Wake Forest University Health Sciences (“WFUHS”). More…PDF(43Kb) [...] CLEVELAND, OH–(Marketwire – July 26, 2010) – Great Lakes Pharmaceuticals, Inc. (“Great Lakes”) announced today the completion of a $3.1 million Series B equity financing led by Charter Life Sciences. More…PDF(90Kb) [...] |
|||
|
Copyright © 2012 Great Lakes Pharmaceuticals - All Rights Reserved |
|||